top of page

Insights and News Curated for Life Science Experts by Life Science Experts....

Go back to...
JMG Logo transparent.png
Executive Spotlights

Precigen Secures $79M in Private Placement for Series A Convertible Preferred Stock and Warrants

Germantown, MD, December 27, 2024 (PRNewswire) -- Precigen, Inc. has entered into a securities purchase agreement for the sale of its 8.00% Series A Convertible Perpetual Preferred Stock in a private placement, raising $79 million in gross proceeds. The transaction also includes warrants allowing investors to purchase up to 52.67 million shares of Precigen's common stock at $0.75 per share. The offering is expected to close by December 30, 2024, subject to customary conditions.


Read full article here.

Recent Posts

See All
Life Science Headlines
bottom of page